Waldenstrom’s Macroglobulinemia: Treatment Options | MyLymphomaTeam

Connect with others who understand.

sign up Log in
Resources
About MyLymphomaTeam
Powered By

Waldenstrom’s Macroglobulinemia: Treatment Options

Medically reviewed by Mark Levin, M.D.
Written by Aminah Wali, Ph.D.
Posted on June 24, 2021

Waldenstrom's macroglobulinemia (WM) — also known as lymphoplasmacytic lymphoma — is a rare blood cancer that forms in cells of the immune system. It is a form of non-Hodgkin lymphoma (NHL), one of the two main categories of lymphoma. Several types of treatment options are available for people living with WM, including chemotherapy, immunotherapy, radiation therapy, targeted drugs, and stem cell transplants.

WM forms in a type of white blood cells called B lymphocytes, or B cells. B cells function as part of the immune system: They help the body recognize and fight infections with proteins known as antibodies, which are made to recognize foreign entities. The cancer cells in WM make abnormally high levels of an antibody called immunoglobulin M (IgM). The antibody molecules made by the cancer cells are all identical and are therefore called a monoclonal protein, or M protein.

WM generally forms in the bone marrow, where the cancer cells multiply and overtake the normal healthy cells This can cause a decrease in a person’s levels of red blood cells, white blood cells, and platelets. WM is an indolent, or slow-growing, form of NHL and may progress over many years before treatment is required.

There are several treatment options available for WM. A person’s recommended treatment regimen will depend on factors such as their health, disease stage, and response to other therapies.

Watch and Wait

WM is a slow-growing disease, so it may not be causing any problems at the time of diagnosis. In such cases, doctors will most likely opt for a “watch-and-wait” approach and will monitor the disease through regular follow-up visits. Regular monitoring allows for quick action should the cancer progress to a point where treatment is required.

Chemotherapy

Chemotherapy is one standard treatment option for WM. There are many types of chemotherapeutic drugs, which can be prescribed alone or in certain combinations.

One combination that may be used to treat WM is called CHOP. It comprises:

Treanda (bendamustine) is another chemotherapy drug that may be used to treat WM.

Chemotherapy is often administered with another type of drug called Rituxan (rituximab).

Immunotherapy

Immunotherapy utilizes the proteins from the immune system to fight cancer cells. Different forms of immunotherapy might be used to treat WM.

Monoclonal Antibodies

Antibodies are proteins that recognize specific molecules, called antigens, that are present on the surface of certain cells. Synthetic (laboratory-made) antibodies are called monoclonal antibodies. Rituxan is the most common monoclonal antibody used in the treatment of WM. It recognizes a molecule called CD20 that is present on the surface of B cells. This allows the drug to target WM cancer cells specifically. Rituximab can be used alone to treat WM or together with CHOP chemotherapy in a regimen known as R-CHOP.

Arzerra (ofatumumab) is another antibody drug that binds the CD20 antigen. It may be prescribed to people who cannot take rituximab.

Immunomodulating Drugs

Immunomodulating drugs help the body fight cancer by boosting a person’s natural immune system. Thalomid (thalidomide) and Revlimid (lenalidomide) are immunomodulating drugs that can be effective at treating WM, particularly in combination with rituximab.

Radiation Therapy

Radiation is not commonly used to treat WM. However, it may be used in some cases to shrink an enlarged organ such as the spleen or lymph nodes.

Plasmapheresis

People with WM may have hyperviscosity syndrome, a condition in which the blood is abnormally thick, or viscous. Hyperviscosity syndrome is caused by the high levels of IgM. Hyperviscosity syndrome is a serious condition that can cause neurological damage and bleeding, but it can be treated with plasmapheresis, or plasma exchange.

The procedure uses a machine to separate the blood cells from the plasma (the liquid part of the blood) containing the IgM protein. New plasma from a healthy donor is mixed with the blood cells and put back into the person receiving treatment. Plasmapheresis does not directly treat the cancer — it is an emergency treatment used to improve a person’s condition until the cancer itself can be treated.

Targeted Drug Therapy

Targeted drugs work by targeting and inhibiting a specific protein or group of proteins. One class of drugs, known as proteasome inhibitors, includes the drug Velcade (bortezomib). Proteasome inhibitors prevent the destruction of proteins that slow cell division, which helps to control the growth of the cancer.

The drug Imbruvica (ibrutinib) is also used to treat WM, either alone or in combination with rituximab. Ibrutinib is part of another class of drugs known as Bruton’s tyrosine kinase (BTK) inhibitors. These prevent the function of the BTK protein, which normally promotes the growth and survival of cells. Inhibiting this protein can slow the growth of WM cells.

Stem Cell Transplantation

For healthier people who are responsive to chemotherapy, a stem cell transplant (also known as a bone marrow transplant) may be recommended. This approach involves replacing the cells in a person’s bone marrow in order to increase the tolerance for higher doses of chemotherapy.

People with WM will more commonly have an autologous stem cell transplantation, in which healthy stem cells are taken from their own body and replaced after the chemotherapy has destroyed the cancer. In some cases, an allogeneic stem cell transplantation that requires stem cells from a healthy donor will be recommended.

Ongoing Research and New Treatments

Several existing targeted drugs are currently being explored as possible treatment options for WM. The U.S. Food and Drug Administration (FDA) has already approved Kyprolis (carfilzomib) — another proteasome inhibitor. The FDA also has approved a class of drugs known as mTOR inhibitors, including Afinitor (everolimus). These drugs block the mTOR cell protein, which normally helps cells grow and divide into new ones. The drug fludarabine, combined with cyclophosphamide, is also sometimes used to treat advanced or symptomatic Waldenstrom's macroglobulinemia.

Chimeric antigen receptor T-cell (CAR-T) therapy is a newer kind of treatment that involves removing immune cells called T cells from a person and engineering them to contain chimeric antigen receptors (CARs) on the surface of the cells. The cells are then put back into the person. There, they can bind to antigens on the cancer cells, using the person’s own immune system to attack the cancer cells. CAR-T therapy has been shown to be effective against WM that has failed to respond well to other treatments.

Clinical trials for potential new therapies are ongoing and are crucial for identifying improved ways to treat WM.

Talk With Others Who Understand

MyLymphomaTeam is the social network for people with lymphoma and their loved ones. On MyLymphomaTeam, more than 8,200 members come together to ask questions, give advice, and share their stories with others who understand life with Hodgkin lymphoma.

Are you or a loved one living with Waldenstrom's macroglobulinemia? Share your experience in the comments below, or start a conversation by posting on MyLymphomaTeam.

Posted on June 24, 2021
All updates must be accompanied by text or a picture.

Become a Subscriber

Get the latest articles about lymphoma sent to your inbox.

Mark Levin, M.D. is a hematology and oncology specialist with over 37 years of experience in internal medicine. Review provided by VeriMed Healthcare Network. Learn more about him here
Aminah Wali, Ph.D. received her doctorate in genetics and molecular biology from the University of North Carolina at Chapel Hill. Learn more about her here

Related Articles

Diffuse large B-cell lymphoma (DLBCL) is staged based on which lymph nodes and organs are involv...

DLBCL Stages: How Is Advanced DLBCL Treated?

Diffuse large B-cell lymphoma (DLBCL) is staged based on which lymph nodes and organs are involv...
Within the first two years of achieving remission after treatment for diffuse large B-cell lympho...

DLBCL Relapse Chances and Treatment Options

Within the first two years of achieving remission after treatment for diffuse large B-cell lympho...
When treatment for diffuse large B-cell lymphoma (DLBCL) successfully kills all detectable lympho...

DLBCL Treatment: What Is Complete Response? How Long Does It Last?

When treatment for diffuse large B-cell lymphoma (DLBCL) successfully kills all detectable lympho...
Burkitt lymphoma is a type of non-Hodgkin lymphoma (NHL) that grows very quickly. People who are...

Burkitt Lymphoma: Treatments and Side Effects

Burkitt lymphoma is a type of non-Hodgkin lymphoma (NHL) that grows very quickly. People who are...
Non-Hodgkin lymphoma (NHL) takes dozens of different forms, and there are many treatment options...

Non-Hodgkin Lymphoma Treatment: What You Need To Know

Non-Hodgkin lymphoma (NHL) takes dozens of different forms, and there are many treatment options...
Undergoing lymphoma treatment can sometimes bring along harsh side effects, including digestive ...

Managing Lymphoma Treatment Side Effects

Undergoing lymphoma treatment can sometimes bring along harsh side effects, including digestive ...

Recent Articles

Welcome to MyLymphomaTeam — the place to connect with others living with lymphoma. This video wi...

Getting Started on MyLymphomaTeam (VIDEO)

Welcome to MyLymphomaTeam — the place to connect with others living with lymphoma. This video wi...
For some people, COVID-19 feels like no more than a minor cold. Unfortunately, this is not typica...

Avoiding COVID-19 With Lymphoma: New Advice From the Leukemia & Lymphoma Society

For some people, COVID-19 feels like no more than a minor cold. Unfortunately, this is not typica...
If you daydream about dessert or yearn for something sweet after every meal, you’re not alone. Lo...

4 Things To Know About Lymphoma and Sugar Cravings

If you daydream about dessert or yearn for something sweet after every meal, you’re not alone. Lo...
Shouldn’t “cured” mean you’ll stay healthy? Although Hodgkin lymphoma (formerly called Hodgkin’s ...

7 Complications of Hodgkin Lymphoma

Shouldn’t “cured” mean you’ll stay healthy? Although Hodgkin lymphoma (formerly called Hodgkin’s ...
Symptoms of lymphoma can develop anywhere on your body, including under your arms. Lymphoma is a ...

6 Lymphoma Symptoms Under the Arms: Lymph Nodes, Armpit Rash, and More

Symptoms of lymphoma can develop anywhere on your body, including under your arms. Lymphoma is a ...
Flow cytometry testing is one way your lymphoma care team may diagnose and monitor your condition...

How Flow Cytometry Is Used To Diagnose and Monitor Lymphoma

Flow cytometry testing is one way your lymphoma care team may diagnose and monitor your condition...
MyLymphomaTeam My lymphoma Team

Thank you for subscribing!

Become a member to get even more:

sign up for free

close